Thalidomide and dexamethasone combination for refractory multiple myeloma

Annals of Oncology

Volumn 12, Issue 7, 2001, Pages 991-995

  Dimopoulos, M A ^a   Zervas, K ^a   Kouvatseas, G ^a   Galani, E ^a   Grigoraki, V ^a   Kiamouris, Ch ^a   Vervessou, E ^a   Samantas, E ^a   Papadimitriou, Ch ^a   Economou, O ^a   Gika, D ^a   Panayiotidis, P ^a   Christakis, I ^a   Anagnostopoulos, N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Dexamethasone; Multiple myeloma; Thalidomide

Indexed keywords

ALKYLATING AGENT; DEXAMETHASONE; THALIDOMIDE;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; EDEMA; FATIGUE; FEMALE; HEADACHE; HUMAN; MALE; MOOD; MULTIPLE MYELOMA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RASH; SOMNOLENCE; SURVIVAL TIME; TIME; TREMOR; VEIN THROMBOSIS; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; DRUG RESISTANCE, NEOPLASM; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; SALVAGE THERAPY; SURVIVAL ANALYSIS; THALIDOMIDE; TREATMENT OUTCOME;

EID: 0034899464     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011132808904     Document Type: Article

References (13)

1. The treatment of multiple myeloma
2. Antitumor activity of thalidomide in refractory multiple myeloma
3. Thalidomide alone or with dexamethasone for multiple myeloma
4. Reporting results of cancer treatment
5. Regression models and life tables
6. Analysis of survival by tumor response
7. Thalidomide for resistant and relapsing myeloma
8. Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma
9. Thalidomide in patients with advanced multiple myeloma
10. Thalidomide-A revival story
11. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
12. Thalidomide with dexamethasone for resistant multiple myeloma
13. Thalidomide plus dexamethasone and thalidomide alone as first line therapy for newly diagnosed myeloma